Our story

Who we are

Syncona founds, builds and funds companies in innovative areas of healthcare, targeting the superior risk-adjusted returns available from commercialising exceptional science.

We found businesses around exceptional science in areas of high unmet medical need, where there is the potential to take a product through to market. Fundamental to each of our investments is the treatment which can be delivered to patients. Our model gives us strategic influence and we work in partnership with our founders and the management teams of our companies to build our companies, bringing the commercial vision – writing the business plan and providing operational input and oversight, with a view to appoint the best talent as the company grows.

We have a deep pool of capital which is fundamental to the delivery of strategy. It enables us to set up companies with ambition of delivering products to market and to fund them over the long-term, providing us with the flexibility to be a significant shareholder at the point of product approval, thereby accessing the superior risk-adjusted returns available for shareholders.

Why we are different

We have an expert team, permanent capital base and long-term product-focused strategy.

Syncona has an expert team with the skill set, track record and strategic capital base to build a sustainable, diverse high-quality portfolio of 15-20 companies. We target 2-3 new portfolio companies a year and our goal is to deliver 3-5 companies, in which we retain a significant ownership position, to the point of product approval. We believe this will enable us to capture the significant value creation opportunity available from commercialising life science innovation and ultimately achieve our ambition to deliver transformational treatments to patients and strong risk-adjusted returns for shareholders.